What is the recommended administration and dosage of Vominore (meclizine hydrochloride + pyridoxine hydrochloride) for nausea and vomiting, including indications, dosing schedule, age limits, contraindications, and maximum duration of use?

Vominore Administration and Dosage

Based on the FDA drug label, Vominore is a topical product for skin irritation (insect bites and minor skin irritations), NOT an oral antiemetic medication, and should be applied to affected areas no more than 3 times daily. 1

Critical Clarification

The FDA-approved Vominore product is contraindicated for children under 6 years of age and is formulated for topical dermal application only to treat itching from insect bites and minor skin irritations. 1

Dosing Instructions for Topical Vominore:

• Application frequency: Apply to affected area not more than 3 times daily 1
• Age restriction: Do not use in children under 6 years; consult a doctor 1
• Testing requirement: Test product on small patch of skin before applying to entire body 1
• Storage: Room temperature 1

Important Caveat

There appears to be confusion regarding this product name. The evidence provided discusses meclizine and pyridoxine combinations for nausea/vomiting treatment 2, 3, 4, 5, but the actual FDA-labeled Vominore product is a topical dermatological preparation, not an oral antiemetic. 1

If you are seeking information about oral meclizine-pyridoxine combinations for nausea and vomiting in pregnancy, the evidence supports:

• First-line use of antihistamines (including meclizine) and doxylamine/pyridoxine combinations for pregnancy-related nausea and vomiting 2
• Safety profile: Meclizine presents low teratogenic risk and can be considered first-choice 4
• Pyridoxine supplementation shows beneficial effects for nausea symptoms 6

However, these recommendations do NOT apply to the FDA-labeled topical Vominore product described in the drug label evidence provided.